ResearcherCapital Medical UniversityNo recent work listed
Qiang He
Matched on ORCID iD 0000-0002-8900-1688; OpenAlex author ID A5100632055, A5100652550, A5113479756. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2020: 2 papers · 2021: none · 2022: 2 papers
Papers 4
- MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. Last author DOI 10.1155/2022/5514715↗
- Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer. Last author DOI 10.1155/2022/9737587↗
- Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. Last author DOI 10.1016/j.ejphar.2020.173225↗
- Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma. Last author DOI 10.1042/bsr20200214↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xin Zhao · 3 shared papers, 2020–2022 · strength 0.37
- Paper MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. DOI 10.1155/2022/5514715↗
- Paper Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcino… DOI 10.1042/bsr20200214↗
- Paper Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharma… DOI 10.1016/j.ejphar.2020.173225↗
- Zhangyong Ren · 3 shared papers, 2020–2022 · strength 0.37
- Paper MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. DOI 10.1155/2022/5514715↗
- Paper Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcino… DOI 10.1042/bsr20200214↗
- Paper Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharma… DOI 10.1016/j.ejphar.2020.173225↗
- Ren Lang · 3 shared papers, 2020–2022 · strength 0.37
- Paper MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. DOI 10.1155/2022/5514715↗
- Paper Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcino… DOI 10.1042/bsr20200214↗
- Paper Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharma… DOI 10.1016/j.ejphar.2020.173225↗
- Zhe Liu · 2 shared papers, 2020 · strength 0.22
- Paper Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcino… DOI 10.1042/bsr20200214↗
- Paper Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharma… DOI 10.1016/j.ejphar.2020.173225↗
- Cheng Ding · 1 shared paper, 2022 · strength 0.19
- Menghua Dai · 1 shared paper, 2022 · strength 0.19
- Junming Xu · 1 shared paper, 2022 · strength 0.15
- Xinxue Zhang · 1 shared paper, 2022 · strength 0.15
- Qing Chen · 1 shared paper, 2022 · strength 0.15
- Zhe Liu · 1 shared paper, 2022 · strength 0.15
- Shaocheng Lyu · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.